From: The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial
Group
TNM Classification
Number of Tumors
BEXIDEM®
BCG
A
Ta Grade 1
T1 Grade 1
Single or multiple
Single
26
29
B
Ta Grade 2
T1 Grade 2
Multiple
C
Ta Grade 3
23